Results 231 to 240 of about 32,908 (264)
Some of the next articles are maybe not open access.
Dual antiplatelet therapy escalation and de-escalation
European Heart Journal: Acute Cardiovascular CareAbstract Dual antiplatelet therapy (DAPT) remains a key element of secondary prevention after percutaneous coronary intervention. However, its optimal duration and intensity continue to pose challenges due to the trade-off between ischaemic protection and bleeding risk.
Antonio Greco +4 more
openaire +2 more sources
International Journal of Cardiology
Optimal antithrombotic therapy after mitral valve transcatheter edge-to-edge repair (TEER) remains uncertain.To compare the efficacy and safety of single antiplatelet therapy (SAPT) versus dual antiplatelet therapy (DAPT) in mitral TEER recipients.We retrospectively queried the TriNetX Global Network, identifying 3325 adult patients who underwent ...
Yaman, Jarrar +7 more
openaire +2 more sources
Optimal antithrombotic therapy after mitral valve transcatheter edge-to-edge repair (TEER) remains uncertain.To compare the efficacy and safety of single antiplatelet therapy (SAPT) versus dual antiplatelet therapy (DAPT) in mitral TEER recipients.We retrospectively queried the TriNetX Global Network, identifying 3325 adult patients who underwent ...
Yaman, Jarrar +7 more
openaire +2 more sources
[New antiplatelet agents and the question of dual antiplatelet therapy].
Der Internist, 2012The introduction of clopidogrel for use with aspirin (ASA) as a dual antiplatelet therapy has markedly reduced the risk of atherothrombotic vessel occlusion in patients with acute coronary syndromes (ACS). However, stronger antiplatelet therapy has also been associated with significant increases in severe bleeding, resulting in no change in mortality ...
openaire +1 more source
Dual antiplatelet therapy duration and mortality
The Lancet, 2015Johann, Auer +2 more
openaire +2 more sources
Effects of dual antiplatelet therapy on graft patency after lower extremity bypass
Journal of Vascular Surgery, 2021Jordan B Stoecker +2 more
exaly
Dual antiplatelet therapy and an anemia subtype
Medicina de Familia. SEMERGEN, 2018openaire +2 more sources

